Imatinib Mesylate
Pricing Report NDC 0054-0248-22

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Imatinib Mesylate (NDC 0054-0248-22) is $3.13689 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 22, 2020.

As a provided by Hikma Pharmaceuticals Usa Inc., this medication is distributed in a 90 TABLET, FILM COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$3.13689
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jul 22, 2020
Billable Units
90 EA
Estimated Package Price
$282.32
Data Status
As of Sep 02, 2020
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0054-0248-22
Description
90 TABLET, FILM COATED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2018, the NADAC wholesale price for (NDC ) has moved within a range of $2.06865 to $6.08965 per EA. Over this 1 year and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$2.0687 - $6.0897
Market Volatility
194.38% Variance
Latest Trend
51.64%
Date Unit Price Unit Source Method Rate
Jul 22, 2020 $3.13689 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 22, 2020 $3.13689 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Feb 19, 2020 $2.06865 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 19, 2020 $2.06865 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Mar 20, 2019 $4.94632 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 20, 2019 $4.94632 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Dec 12, 2018 $6.08965 EAC/I - Chain or Independent PharmacyCode 4G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026